The core site in the Moloney murine leukemia virus (Moloney MLV) enhancer w
as previously shown to be an important determinant of the T-cell disease sp
ecificity of the virus. Mutation of the core site resulted in a significant
shift in disease specificity of the Moloney virus from: T-cell leukemia to
erythroleukemia. We and others have since determined that a protein that b
inds the core site, one of the core-binding factors (CBF) is highly express
ed in thymus and is essential for hematopoiesis. Here we test the hypothesi
s that CBF plays a critical role in mediating pathogenesis of Moloney MLV i
n vivo. We measured the affinity of CBE for most core sites found in MLV en
hancers, introduced sites with different affinities for CBF into the Molone
y MLV genome, and determined the effects of these sites on viral pathogenes
is. We found a correlation between CBF affinity and the latent period of di
sease onset, in that Moloney MLVs with high-affinity CBF binding sites indu
ced leukemia following a shorter latent period than viruses with lower-affi
nity sites. The T-cell disease specificity of Moloney MLV also appeared to
correlate with the affinity of CBF for its binding site. The data support a
role for CBF in determining the pathogenic properties of Moloney MLV.